FDA accuses Mid-Link of copying or falsifying medical device test data
FDA officials said the agency would reject all data from the Chinese service provider’s studies after the company failed to address concerns outlined in a warning letter last year.
FDA officials said the agency would reject all data from the Chinese service provider’s studies after the company failed to address concerns outlined in a warning letter last year.
